The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.
Official Title: Blood Collection Sub-Study of Exact Sciences Protocol 2018-10: "An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now"
Study ID: NCT03741166
Brief Summary: The primary objective of this sub-study, 2018-10B, is to collect blood specimens to assess new biomarkers for the detection of Colorectal Cancer (CRC).
Detailed Description: Subjects who consent to enroll in Exact Sciences Protocol 2018-10, will be asked to participate in this sub-study. Subjects enrolled in the Exact Sciences Protocol 2018-10, who provide written informed consent to participate in this sub-study, will have a blood sample collected at enrollment.
Minimum Age: 45 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: Yes
Mayo Clinic Arizona, Phoenix, Arizona, United States
Ventura County Gastroenterology, Camarillo, California, United States
Alliance Research Centers, Laguna Hills, California, United States
Focilmed, Oxnard, California, United States
Desert Oasis Healthcare Medical Group, Palm Springs, California, United States
Gastroenterology Associates of Fairfield County, Bridgeport, Connecticut, United States
Yale University Section of Digestive Diseases and Liver Diseases, New Haven, Connecticut, United States
Precision Clinical Research, LLC, Lauderdale Lakes, Florida, United States
Northshore University Health System Evanston Hospital, Evanston, Illinois, United States
DM Clinical Research- Southwest Gastroenterology, Oak Lawn, Illinois, United States
Deaconess Clinic- Mt. Pleasant, Evansville, Indiana, United States
Deaconess Clinic- Gateway, Newburgh, Indiana, United States
Johnson County ClinTrials, LLC, Lenexa, Kansas, United States
New Orleans Research Institue, Metairie, Louisiana, United States
Delta Research Partners, LLC, Monroe, Louisiana, United States
Louisiana Research Center, Shreveport, Louisiana, United States
Investigative Clinical Research, Annapolis, Maryland, United States
Centennial Medical Group, Elkridge, Maryland, United States
Capitol Research, Rockville, Maryland, United States
Commonwealth Clinical Studies, Brockton, Massachusetts, United States
Mayo Clinic Rochester, Rochester, Minnesota, United States
United Medical Associates, Binghamton, New York, United States
Asheville Gastroenterology Associates, Asheville, North Carolina, United States
Charlotte Gastroenterology & Hepatology, PLLC, Charlotte, North Carolina, United States
Wilmington Gastroenterology Associates, Wilmington, North Carolina, United States
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Great Lakes Gastroenterology Research, LLC, Mentor, Ohio, United States
Comprehensive Internal Medicine, Inc., Wooster, Ohio, United States
Family Practice Center of Wooster, Inc./Clinical Trial Developers, Wooster, Ohio, United States
Gastroenterology Associates, PA, Greenville, South Carolina, United States
Gastro One, Germantown, Tennessee, United States
Quality Medical Research, PLLC, Nashville, Tennessee, United States
Austin Regional Clinic, Austin, Texas, United States
University of Texas Health Science Center- McGovern Medical School, Houston, Texas, United States
DM Clinical Research- PCP for Life, Houston, Texas, United States
Virginia Gastroenterology Institute, Suffolk, Virginia, United States
Wisconsin Center for Advanced Research, Milwaukee, Wisconsin, United States
Name: Thomas Imperiale
Affiliation: Indiana University
Role: PRINCIPAL_INVESTIGATOR